Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KP 10614 is a new prostacyclin analog that inhibits platelet-polymorphonuclear leukocyte interaction.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 1,175,000 |
50 mg | 約10-14 週間 | ¥ 1,556,000 |
100 mg | 約10-14 週間 | ¥ 2,226,500 |
説明 | KP 10614 is a new prostacyclin analog that inhibits platelet-polymorphonuclear leukocyte interaction. |
分子量 | 372.5 |
分子式 | C23H32O4 |
CAS No. | 130273-99-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KP 10614 130273-99-3 FK070 KDI792 KP-10614 FK-070 KDI-792 HCl KDI-792 hydrochloride KDI 792 KP10614 Inhibitor inhibitor inhibit